Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:01:48.826Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:01:48.826Z.
Quote observation: 2026-10-06T14:29:52.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: aba6dde202523e327e8df603f06c84cdc8b0caa676e2570b33753db7f555988b
FORWARD PE RATIO
N/A
Caring Brands, Inc.
Market Cap
$10.09M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Caring Brands, Inc. (CABR) | $10.09M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $9.98M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.92M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.88M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.79M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.45M | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.47M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.32M | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.88M | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.93M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
